trial summary · NCT04861077
Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)
Monitoring Breast Cancer Immunotherapy Treatment With Advanced PET/MRI: A Pilot Study
Trial record from the TrialBase DB dataset, status RECRUITING, condition Triple Negative Breast Cancer, sponsored by University of Alabama at Birmingham. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
This clinical study will investigate the utility of Fludeoxyglucose (18F) fluoromisonidazole (FMISO), in patients diagnosed with triple negative breast cancer (stage II-IV disease), to monitor and predict the effect of immunotherapy. This is a parallel imaging study to current treatment strategies and no clinical decisions or outcomes will be based on the imaging. If promising, this data will be used to design larger trials. A total of 20 patients will be recruited for this study. This trial will not designate the participant's treatment plan; they will be eligible based on their treatment plan designated from their oncologist.
Source record: https://clinicaltrials.gov/study/NCT04861077
Facts
| registry id | NCT04861077 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | EARLY_PHASE1 |
| study type | INTERVENTIONAL |
| lead condition | Triple Negative Breast Cancer |
| sponsor | University of Alabama at Birmingham |
| sponsor class | OTHER |
| enrollment | 20 |
| start date | 2027-06 |
| primary completion | 2030-08 |
| completion | 2030-08 |
| results posted | not reported |
Conditions
- Triple Negative Breast Cancer
Interventions
- [18F]FMISO-PET with contrast-enhanced MRI
Countries
- United States
Intervention types: DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.